Prenosis
Prenosis
Prenosis is a clinical AI company focused on transforming diagnosis and care in acute settings by combining holistic molecular and clinical data with machine learning. The company develops decision-support diagnostics that identify patient-specific biological signals to improve early detection and management of critical conditions, particularly sepsis.
About the product and mission
Prenosis’ Sepsis ImmunoScore is an AI-enabled diagnostic tool designed to support clinicians in detecting sepsis earlier and more accurately by tailoring risk assessment to each patient’s biology. The company emphasizes responsible, transparent AI and integration with clinical workflows to improve outcomes and reduce alert fatigue.
Prenosis works with hospitals and health systems to validate and deploy its precision-medicine platform for sepsis and other critical conditions (pneumonia, ARDS, AKI, acute heart failure).
Company details
Industry: Biotechnology Research. Headquarters: Chicago, Illinois. Founded: 2014. Company size: 11-50 employees.
Specialties:
- artificial intelligence
- machine learning
- healthcare
- precision medicine
Recent milestones include Series A financing and a BARDA contract to support pivotal studies and commercial delivery of Sepsis ImmunoScore. Prenosis posts job openings on LinkedIn and partners with clinical and research organizations to advance regulatory and clinical validation.